CTKB
Cytek Biosciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.30
+1.73%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.14x
- Price / sales
- 3.33x
- Price / cash flow
- -114.10x
Enterprise value
- Enterprise value
- $453.4M
- EV / sales
- 2.19x
- EV / EBITDA
- -16.70x
- EV / EBIT
- -10.15x
- Market cap
- $688.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026